NCT05722262View on ClinicalTrials.gov

Study to Demonstrate the Bioequivalence of Single Oral Administration of K-001 Relative to Single Oral Coadministration of Separate Tablets of K-877-ER and CSG452

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 24, 2023

Primary Completion Date

April 1, 2023

Study Completion Date

April 5, 2023

Conditions
Healthy
Interventions
DRUG

K-001

K-877-ER and CSG452 combination tablet

DRUG

K-877-ER

K-877-ER tablet

DRUG

CSG452

CSG452 tablet

Trial Locations (1)

78744

PPD - Austin Research Unit, Austin

Sponsors
All Listed Sponsors
lead

Kowa Research Institute, Inc.

INDUSTRY